Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2’-deoxycytidine
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 130 (2) , 181-190
Abstract
No abstract availableKeywords
Funding Information
- School of Dentistry, University of Michigan
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Educação (BEX / 88881.132588/2016-01, BEX / 88881.187926/2018-01)
This publication has 54 references indexed in Scilit:
- Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinomaCancer Letters, 2013
- Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencingLaboratory Investigation, 2012
- The functions and regulation of the PTEN tumour suppressorNature Reviews Molecular Cell Biology, 2012
- PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantificationNucleic Acids Research, 2009
- Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin SignalingPLOS Biology, 2009
- Dysregulated molecular networks in head and neck carcinogenesisOral Oncology, 2009
- Molecular Cross-Talk between the NFκB and STAT3 Signaling Pathways in Head and Neck Squamous Cell CarcinomaNeoplasia, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997